Clinical Sequencing
News on sequencing-based testing, NGS gene panels, & diagnostic exomes in genetics, genomics, and molecular diagnostics.
The company said the results highlight precision oncology implementation challenges and its test's ability to help overcome these issues.
Cancer Mutation Detection Depends on Choices at Each Step of Sequencing, Analysis Pipeline
Researchers found read coverage and variant callers influence whole-genome sequencing reproducibility, though other parts of the process may also have an effect.
Multiple studies are showing that long reads can deliver results where short reads can't, but many barriers remain on the road to the clinic.
Qiagen, OncXerna Therapeutics Ink Companion Dx Development, Technology-Licensing Deal
The partners will develop an NGS companion diagnostic for navicixizumab, which OncXerna is developing as a treatment for patients with ovarian cancer.
Single Metastatic Cancer Genome Analysis Appears Sufficient to ID Biomarkers, Treatment Options
For many metastatic cancer patients, actionable genomic alterations uncovered in the initial analysis did not change much in later biopsies.